Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major Patients; New Indications for Combination Therapy

BACKGROUND: Treatment guidelines contraindicate ribavirin for treatment of hepatitis C virus (HCV) infection in thalassemia major patients. Nevertheless, the current evidence suggests that ribavirin might be tolerated by these patients. OBJECTIVES: Despite this evidence, low dose ribavirin combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabatabaei, Seyed Vahid, Alavian, Seyed Moayed, Keshvari, Maryam, Behnava, Bita, Miri, Seyyed Mohammad, Karimi Elizee, Pegah, Zamani, Farhad, Amini Kafiabad, Sedigheh, Gharehbaghian, Ahmad, Hajibeigy, Bashir, Lankarani, Kamran Bagheri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412553/
https://www.ncbi.nlm.nih.gov/pubmed/22879826
http://dx.doi.org/10.5812/hepatmon.6592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412553/
https://www.ncbi.nlm.nih.gov/pubmed/22879826
http://dx.doi.org/10.5812/hepatmon.6592

Ejemplares similares